Pharmaceuticals, Biotechnology and Life Sciences
INEOS Styrolution, the global leader in styrenics, will present new product highlights and a range of new applications for the healthcare industry at Pharmapack 2017 in Paris (Paris Expo, Porte de Versailles).
Eli Lilly begins new year with reorganizing its leadership structure to pursue better growth opportunities in the upcoming years. The Chief Executive Officer of Lilly, David A. Ricks, who’s new position is also one among the latest promotions, said that the changes made to pharmaceutical therapeutics and geographic business should simplify and maximize the company’s late-stage pipeline and new drugs, as well as to improve productivity.
Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.
Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country…
OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.
Sanofi’s Soliqua 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies.
J&J’s DePuy Synthes Products, Inc. has bought asset and signed development agreement with Interventional Spine, Inc., a privately held manufacturer…
Eli Lilly’s subsidiary Elanco US has completed the acquisition of Boehringer Ingelheim Vetmedica, Inc’s (BIVI) U.S. feline, canine and rabies vaccines…
Sanofi has starts new year with big changes. In two separate statements the company announced closing a deal and ending a joint venture.
Gilead Sciences has strengthened its lines with newly appointed Hematology and Oncology Therapeutic Area Head, who came from Novartis.